Polygiene (POLYG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Q1 sales were SEK 31 million, down 25% year-over-year, with 8.5% of the decline due to FX effects and elevated distributor inventories after a strong prior year.
Gross margin improved to 69.5% from 67.4% year-over-year, aided by price adjustments, FX, and disciplined cost control despite higher silver and input costs.
Operating costs decreased by nearly SEK 3 million, reflecting lower development, travel, management, legal, and IR costs, and a smaller workforce.
EBITDA was SEK 1.2 million (vs. SEK 3.1 million last year); EBIT was -SEK 0.1 million (vs. SEK 1.6 million last year).
Operational focus included the launch of OdorCrunch 2.0, new partnerships with Salomon and Chemco International, and expanded collaborations with HEAD and Le Coq Sportif.
Financial highlights
Net cash position at SEK 43.5 million, down from SEK 61.9 million year-over-year.
Addmaster segment now represents almost 60% of total sales, up from 46% last year.
Polygiene segment sales dropped 42%, now below 50% of total sales.
Americas and Global regions saw the largest sales declines; APAC was flat excluding FX.
Earnings per share: SEK -0.03 (0.00); equity ratio: 91.0% (91.3%).
Outlook and guidance
Disciplined execution and cost control remain priorities, with focus on managing silver price volatility, innovation, restoring Americas growth, and repositioning Addmaster.
Strategy execution includes deepening partner relationships, expanding into new markets, and investing in sustainability and hygiene innovation.
The external environment remains complex due to geopolitical tensions and volatile input costs, but the diversified model and global footprint provide resilience.
Latest events from Polygiene
- Sales and margins fell in 2025, with FX and silver prices as major headwinds.POLYG
Q4 202512 Feb 2026 - Q2 net sales up 43% to SEK 36.4m, with strong APAC growth and positive EBITDA.POLYG
Q2 20243 Feb 2026 - Sales up 42% year-over-year, strong margins, positive cash flow, and robust regional growth.POLYG
Q3 202418 Jan 2026 - Sales up 45% in Q4, strong margins, cash flow, and positive outlook for 2025.POLYG
Q4 202423 Dec 2025 - 18% sales growth, strong margins and cash, new tech, and first dividend proposed.POLYG
Q1 202524 Nov 2025 - Sales fell 12% and EBITDA turned negative, but innovation and partnerships support future growth.POLYG
Q2 202516 Nov 2025 - Q3 2025 net sales fell 10.9%, but US growth and new products support a strong outlook.POLYG
Q3 202523 Oct 2025